Overview

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether early hormonotherapy is effective in the treatment of high risk prostate cancer patients after radical prostatectomy.
Phase:
N/A
Details
Lead Sponsor:
Kaunas University of Medicine
Treatments:
Triptorelin Pamoate